Search results
Tarun W Dasari
Author
Carles Bautista
Research Area(s) / Expertise:
Job title: Consultant Paediatric and Interventional Cardiologist. Royal Brompton Hospital, London, UK
Author
Author(s):
Milind Y Desai
Added:
8 months ago
ESC Congress 2025 - ODYSSEY-HCM finds no improvements in patients with non-obstructive cardiomyopathy when treated with mavacamten.Dr Milind Desai (Cleveland Clinic, US) joins us to discuss findings from the ODYSSEY-HCM trial, evaluating the safety, tolerability, and efficacy of mavacamten in patients with symptomatic non-obstructive hypertrophic cardiomyopathy.The ODYSSEY-HCM study was a…
View more
C Noel Bairey Merz
Research Area(s) / Expertise:
Job title: Cardiologist
Author
Author(s):
Milind Y Desai
Added:
1 year ago
AHA Conference 2024 - 128-week results of VALOR-HCM investigating mavacamten treatment for patients with hypertrophic cardiomyopathy (HCM) referred for septal reduction therapy (SRT) procedures.Dr Milind Desai (Cleveland Clinic, Ohio, US) joins us onsite at AHA Conference to discuss the findings from VALOR-HCM (NCT04349072).VALOR-HCM is a randomized, double-blind, placebo-controlled, phase 3…
View more
Sohail Q Khan
Job title: Consultant Interventional Cardiologist
Author
Amina Rakisheva
Research Area(s) / Expertise:
Job title: Consultant in Cardiology Department
Author
Undiagnosed Sleep Apnoea Linked to Adverse Myocardial Remodelling in Hypertrophic Cardiomyopathy
Added:
8 months ago
Source:
Radcliffe Cardiology
News
Eric Eeckhout
Job title: Associate Professor of Cardiology
Author
Orly Vardeny
Research Area(s) / Expertise:
Job title: Associate Professor of Medicine
Author